iifl-logo

Hindustan Bio Sciences Ltd Board Meeting

Add as a Preferred Source on Google
7.86
(0.38%)
Jun 3, 2026|05:30:00 AM

Hind.Bio Science CORPORATE ACTIONS

03/06/2025calendar-icon
03/06/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting30 May 202619 May 2026
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Hindustan Bio Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations 2015
Board Meeting31 Jan 202619 Jan 2026
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 ,inter alia, to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations, 2015. Un-audited results for quarter ended 31-12-2025. (As per BSE announcement dated on : 31.01.2026)
Board Meeting31 Oct 202516 Oct 2025
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 inter alia to consider and approve Unaudited Standalone Financial Results for the Second quarter and half year ended on September 30 2025 along with Limited Review Report Outcome of board meeting held on 31-10-2025 (As Per BSE Announcement Dated On : 31.10.2025)
Board Meeting31 Jul 202519 Jul 2025
Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve the following: 1. Un-audited financial results of the company for the first quarter ended on 30-06-2025 2 Any other matter with the permission of Chair The board of Directors in its meeting held on Thursday, July 31, 2025 approved the Un-audited Standalone Financial Results of the Company for the First Quarter ended on June 30, 2025. (As per BSE Announcement Dated on 31/07/2025)

Hind.Bio Science: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.